Zentek Announces Purchase Order from Dexterra Group Inc. for ZenGUARD(TM) Enhanced Air Filters
Zentek has secured a new purchase order for its ZenGUARD Enhanced Air Filters from Dexterra Group, marking a significant commercial milestone. The filters will be deployed at the Forensic Services and Coroner's Complex (FSCC) in Toronto, Ontario, where Dexterra manages integrated facility operations.
This development represents a strategic expansion of ZenGUARD's market presence, complementing two key business channels:
- An exclusive procurement opportunity with the Government of Canada
- Previously announced distribution agreements
The company views this order as an important indicator of growing ZenGUARD adoption in the Canadian market. Zentek, traded on both Nasdaq (ZTEK) and TSX-V (ZEN), continues to focus on intellectual property development and commercialization.
Zentek ha ottenuto un nuovo ordine di acquisto per i suoi filtri d'aria migliorati ZenGUARD da Dexterra Group, segnando un importante traguardo commerciale. I filtri saranno installati presso il Forensic Services and Coroner's Complex (FSCC) di Toronto, Ontario, dove Dexterra gestisce le operazioni integrate della struttura.
Questo sviluppo rappresenta un'espansione strategica della presenza di ZenGUARD sul mercato, integrando due canali commerciali chiave:
- Un'opportunità di approvvigionamento esclusiva con il Governo del Canada
- Accordi di distribuzione precedentemente annunciati
L'azienda considera questo ordine un indicatore importante della crescente adozione di ZenGUARD nel mercato canadese. Zentek, quotata sia al Nasdaq (ZTEK) che alla TSX-V (ZEN), continua a concentrarsi sullo sviluppo e la commercializzazione della proprietà intellettuale.
Zentek ha asegurado una nueva orden de compra para sus Filtros de Aire Mejorados ZenGUARD por parte de Dexterra Group, marcando un hito comercial significativo. Los filtros se desplegarán en el Forensic Services and Coroner's Complex (FSCC) en Toronto, Ontario, donde Dexterra gestiona las operaciones integradas de las instalaciones.
Este desarrollo representa una expansión estratégica de la presencia de ZenGUARD en el mercado, complementando dos canales comerciales clave:
- Una oportunidad exclusiva de adquisición con el Gobierno de Canadá
- Acuerdos de distribución anunciados previamente
La compañía considera este pedido como un indicador importante de la creciente adopción de ZenGUARD en el mercado canadiense. Zentek, cotizada tanto en Nasdaq (ZTEK) como en TSX-V (ZEN), continúa enfocándose en el desarrollo y la comercialización de propiedad intelectual.
Zentek이 Dexterra Group으로부터 ZenGUARD 향상 공기 필터에 대한 새로운 구매 주문을 확보하며 중요한 상업적 이정표를 달성했습니다. 이 필터들은 Dexterra가 통합 시설 운영을 관리하는 온타리오 주 토론토의 Forensic Services and Coroner's Complex (FSCC)에 배치될 예정입니다.
이번 개발은 ZenGUARD의 시장 입지를 전략적으로 확장하는 것으로, 두 가지 주요 사업 채널을 보완합니다:
- 캐나다 정부와의 독점 구매 기회
- 이전에 발표된 유통 계약
회사는 이 주문을 캐나다 시장에서 ZenGUARD 채택 증가의 중요한 지표로 보고 있습니다. 나스닥(ZTEK)과 TSX-V(ZEN) 양쪽에 상장된 Zentek은 지적 재산 개발 및 상용화에 계속 집중하고 있습니다.
Zentek a obtenu une nouvelle commande pour ses filtres à air améliorés ZenGUARD de la part de Dexterra Group, marquant une étape commerciale importante. Les filtres seront déployés au Forensic Services and Coroner's Complex (FSCC) à Toronto, en Ontario, où Dexterra gère les opérations intégrées des installations.
Cette évolution représente une expansion stratégique de la présence de ZenGUARD sur le marché, complétant deux canaux commerciaux clés :
- Une opportunité d'approvisionnement exclusive avec le gouvernement du Canada
- Des accords de distribution annoncés précédemment
L'entreprise considère cette commande comme un indicateur important de l'adoption croissante de ZenGUARD sur le marché canadien. Zentek, cotée à la fois au Nasdaq (ZTEK) et à la TSX-V (ZEN), continue de se concentrer sur le développement et la commercialisation de sa propriété intellectuelle.
Zentek hat eine neue Bestellung für seine ZenGUARD Enhanced Luftfilter von der Dexterra Group erhalten, was einen bedeutenden kommerziellen Meilenstein darstellt. Die Filter werden im Forensic Services and Coroner's Complex (FSCC) in Toronto, Ontario, eingesetzt, wo Dexterra die integrierten Anlagenbetriebe verwaltet.
Diese Entwicklung stellt eine strategische Erweiterung der Marktpräsenz von ZenGUARD dar und ergänzt zwei wichtige Geschäftskanäle:
- Eine exklusive Beschaffungsmöglichkeit mit der kanadischen Regierung
- Bereits angekündigte Vertriebsvereinbarungen
Das Unternehmen sieht diese Bestellung als wichtigen Indikator für die zunehmende Akzeptanz von ZenGUARD auf dem kanadischen Markt. Zentek, das sowohl an der Nasdaq (ZTEK) als auch an der TSX-V (ZEN) gehandelt wird, konzentriert sich weiterhin auf die Entwicklung und Kommerzialisierung von geistigem Eigentum.
- New purchase order secured from Dexterra for ZenGUARD Enhanced Air Filters
- Expansion of customer base into government facilities through FSCC implementation
- Existing exclusive procurement opportunity with Government of Canada indicates potential for larger market penetration
- Order size and financial terms not disclosed
- Timeline for revenue recognition not specified
Insights
Zentek secures government facility purchase order for air filters, representing early market adoption without disclosed financial impact.
This announcement reveals that Zentek has secured a purchase order from the Forensic Services and Coroner's Complex (FSCC) in Toronto for their ZenGUARD™ Enhanced Air Filters. The company states they are currently fulfilling this order, indicating recent commercial activity.
The FSCC is a government facility where Dexterra Group provides integrated facility management services. This represents a specific example of institutional adoption in the Canadian market, which Zentek appears to be targeting based on their mention of government procurement opportunities and previous distribution agreements.
Without disclosure of order size, value, or implementation timeline, the immediate material impact remains unclear. The company characterizes this as "another data point toward meaningful adoption" of their product in Canada, suggesting this is part of a broader commercialization effort rather than a standalone significant event.
The air filtration market has seen increased institutional attention following pandemic concerns, though the article provides no specific competitive or market size information. For Zentek, as an intellectual property development company, demonstrating commercial traction with institutional customers represents a necessary step in their product commercialization journey.
Zentek's new air filter order shows continued commercialization progress, though financial impact remains undisclosed.
This purchase order announcement from the Forensic Services and Coroner's Complex (FSCC) represents visible commercial progress for Zentek's ZenGUARD™ Enhanced Air Filters. However, the announcement lacks financial details including order value, volume, and revenue timing, making material impact assessment impossible.
The company's description of this as "another data point toward meaningful adoption" positions this as incremental progress rather than a transformative deal. Zentek references the context of anticipated Government of Canada demand through an exclusive procurement opportunity and previously announced distribution agreements, suggesting this is part of their broader Canadian market entry strategy.
For an intellectual property development and commercialization company like Zentek, customer adoption provides important validation, though investors should note the absence of financial metrics prevents assessment of revenue materiality. The company's successful penetration of a government facility may demonstrate product market fit in institutional settings where air quality standards are important.
Without order size details or mention of potential follow-on opportunities, this announcement confirms commercial activity but offers limited insight into revenue impact or growth trajectory. For Zentek shareholders, this represents a positive step in commercialization but with undetermined financial significance.
GUELPH, ON / ACCESS Newswire / April 29, 2025 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization Company, is pleased to announce that the Forensic Services and Coroner's Complex ("FSCC") in Toronto, Ontario - where Dexterra Group Inc. ("Dexterra") provides integrated facility management services - has issued a purchase order for the procurement of ZenGUARD™ Enhanced Air Filters to be used across its facility. The Company is in the process of fulfilling this purchase order.
In addition to anticipated Government of Canada demand through its exclusive procurement opportunity - and its previously announced distribution agreements - the Company believes this represents another data point toward meaningful adoption of ZenGUARDTM Enhanced Air Filters in Canada.
About Dexterra Group
Dexterra employs more than 9,000 people, delivering a range of support services for the creation, management, and operation of infrastructure across Canada and the U.S. Powered by people, Dexterra brings best-in-class regional expertise to every challenge and delivers innovative solutions, giving clients confidence in their day-to-day operations. Activities include a comprehensive range of integrated facilities management services, industry-leading workforce accommodation solutions and other support services for diverse clients in the public and private sectors. Learn more at Dexterra.com.
About Ontario Centre of Forensic Sciences
Led by James Quinn, Dexterra's Facility General Manager, FSCC, is at the forefront of innovation, adopting technologies that enhance indoor air quality, building decarbonization, and occupant experience. Their commitment to sustainability has earned numerous awards, including:
The 2024 Business Intelligence Group Sustainability Award, the BOMA BEST Award (Universal Facility category).
The 2023 NAFA Clean Air Award.
The Canadian Council for Public-Private Partnerships National Awards for Innovation & Excellence recognized the complex with the ESG Silver Award for its sustainable infrastructure efforts.
This reputation as a leader in the facilities management space has led many other entities that are responsible for numerous institutional and commercial building to look to James and his team for implementing new innovative products and best practices like the adoption of ZenGUARD™ Enhanced Air Filters.
James Quinn, Facility General Manager, FSCC, commented, "I have been following graphene and its development journey for several years and have expected that its unique properties and versatility would have the potential to enhance many indoor air quality solutions and building decarbonization initiatives. When we became aware that ZenGUARD™ Enhanced Air Filters were accomplishing this with graphene and silver without relying on more dense filters and increased energy consumption, we were immediately interested. At Dexterra, we are constantly searching for new innovations that can help us achieve our building efficiency goals - and we look forward to adopting ZenGUARDTM Enhanced Air Filters across our facility and working with Zentek to share this real-world return on investment opportunity with many others across Canada. We also look forward to working with Zentek on developing other new graphene-enhanced indoor air quality solutions focused on reducing carbon emissions."
Zentek CEO Greg Fenton commented, "As recognized leaders in the facilities management space, we are extremely proud to have our flagship product and its robust value proposition be recognized by James and the Dexterra team. We see this as an excellent opportunity to share our unique value proposition and this success story with many others across the Dexterra network to increase adoption in Canada. Installing ZenGUARD™ Enhanced Air Filters and working with James and his team to develop new graphene-based technologies to improve indoor air quality and reduce emissions aligns perfectly with our vision of a healthier and safer world through nanotechnology."
About Zentek Ltd.
Zentek is an ISO 13485:2016 certified intellectual property technology company focused on the research, development and commercialization of novel products seeking to give the company's commercial partners a competitive advantage by making their products better, safer, and greener.
Zentek's patented technology platform ZenGUARD™ is shown to have enhanced viral filtration efficiency for surgical masks and aims to do the same for HVAC (heating, ventilation, and air conditioning) systems. Zentek's ZenGUARD™ production facility is in Guelph, Ontario.
For further information on Zentek:
Ryan Shacklock
Senior VP, Strategy & Business Development
Email: rshacklock@zentek.com
Phone: 306-270-9610
To find out more about Zentek, please visit our website at www.Zentek.com. A copy of this news release and all material documents in respect of the Company may be obtained on Zentek's SEDAR+ profile at http://www.sedarplus.ca/.
Forward-Looking Statements
This news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE: Zentek Ltd.
View the original press release on ACCESS Newswire